Home » Newsletters » BioWorld Asia

BioWorld Asia

June 13, 2001

View Archived Issues

Ireland Pursues Position As Biotech Manufacturing Hub

London Group Taking Steps To Keep Growing Companies In City

Cerep Plans To Raise $34M To Add Flexibility, Programs

Other News To Note

FDA Deals Antisoma Setback With New Study Requirements

Delivery Company Ethypharm Plans IPO On Paris Exchange

Morphochem, Sequenom Enter Diabetes, Cancer Discovery Deal

Angiogenesis Research Spawns ALS Mouse Model, New Insights

Commission Funds Project To Make Mouse Models Available

Commissions Says Biotech Gaining Momentum In Europe

Industry Associations Teaming To Help Small European Firms

Genfit Consolidates Operations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...